L-amino Acid Production via yeaS Gene Mutation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing L-amino acids, such as L-cysteine, face limitations in efficiency and productivity, particularly in bacteria like Escherichia and Corynebacterium, where feedback inhibition and decomposition systems hinder optimal production levels.
Innovation Solution
Introducing specific mutations into the yeaS gene of bacteria belonging to the Enterobacteriaceae family, such as replacing threonine at position 28, phenylalanine at position 137, and leucine at position 188 with alternative amino acids, enhances the bacterium's ability to produce L-amino acids by improving enzyme activity and resistance to feedback inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If feedback inhibition systems are active in bacteria, then bacterial growth and metabolism are regulated, but L-amino acid production is limited
Solution Approach 1:
The patent extracts and removes the feedback inhibition mechanism from the bacterial metabolic system by deleting or mutating specific genes (such as cysR, cysB, or other regulator genes) that mediate feedback inhibition. This allows the biosynthesis pathway to operate without end-product inhibition, continuously producing L-amino acids at higher rates.
Solution Approach 2:
The patent changes the regulatory parameters of the bacterial system by modifying gene expression levels, promoter strength, or enzyme kinetics through genetic engineering. This alters the metabolic flow parameters to favor continuous amino acid production rather than regulated production with feedback inhibition.
2Productivity
If decomposition systems are active in bacteria, then metabolic balance is maintained, but L-amino acid accumulation is reduced
Solution Approach 1:
The patent removes the decomposition pathways by deleting or inactivating genes encoding enzymes that degrade L-amino acids (such as cysteine desulfurase, transaminases, or other catabolic enzymes). This prevents loss of produced amino acids and enables their accumulation in the culture medium.
Solution Approach 2:
The patent converts the potentially harmful decomposition of L-amino acids into a benefit by engineering strains that redirect metabolic flux away from degradation pathways and toward product accumulation, thereby transforming a loss mechanism into a production advantage.
3Productivity
If wild-type bacterial strains are used, then natural metabolism is maintained, but production efficiency is low
Solution Approach 1:
The patent systematically changes multiple genetic and metabolic parameters simultaneously - including overexpressing biosynthesis enzymes, deleting regulatory genes, and modifying transporter proteins - to create an optimized production strain that achieves high efficiency despite increased genetic complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified bacteria exhibit increased L-amino acid production and resistance, allowing for efficient fermentation and accumulation of L-amino acids like L-cysteine, exceeding production levels of wild-type strains.
Implementation Method 1
replacing threonine at position 28, phenylalanine at position 137, and leucine at position 188 with alternative amino acids, enhances the bacterium's ability to produce L-amino acids by improving enzyme activity
Implementation Method 2
allowing for efficient fermentation and accumulation of L-amino acids like L-cysteine, exceeding production levels of wild-type strains
Data Source
AI summary
A bacterium belonging to the family Enterobacteriaceae, which has an ability to produce an amino acid such as L-cysteine and has been modified to have specific mutation in the yeas gene, is cultured in a medium, and the L-amino acid is collected from the medium.